2[3-Cyano-4-(2-Methyl Propoxy)Phenyl]4-Methyl-5-Thiazole Carboxylic Acid Ethyl

2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid ethyl ester (CAS 144060-98-0) functions as the penultimate intermediate in the convergent synthesis of the xanthine oxidase inhibitor febuxostat, where the ethyl carboxylate serves as a protected prodrug precursor that is hydrolyzed to the active free acid in the final step. A commercial technical-grade designation such as FEB-EE-99 typically distinguishes material meeting a minimum chromatographic purity of 99.5% (HPLC, area% at λ = 315 nm) from lower-purity research-grade lots; the specification further mandates a single largest unknown impurity ≤ 0.10% and total unspecified impurities ≤ 0.30%. The compound is a white to off-white crystalline powder with a melting endotherm onset of 148–150 °C (DSC, 10 K/min under N₂), exhibiting negligible solubility in water (< 1 µg/mL at 25 °C) but freely soluble in dimethylformamide, dimethyl sulfoxide, and tetrahydrofuran. Its molecular formula is C₁₈H₂₀N₂O₃S, and the molecular weight is 344.43 g/mol.


What role does this ester serve in the convergent synthesis of febuxostat?

In the standard manufacturing route, a biaryl thiazole core is assembled via a Hantzsch-type condensation or a palladium-catalyzed cross-coupling between a pre-formed 4-methylthiazole-5-carboxylate synthon and a functionalized benzonitrile. When the ethyl ester is employed, the ester moiety remains intact through the coupling sequence—typically a Suzuki-Miyaura reaction using Pd(PPh₃)₄ (0.5–1.0 mol%) and aqueous Na₂CO₃ in a toluene/ethanol biphasic system at 75–80 °C—thereby avoiding the solubility and purification challenges associated with the free carboxylic acid. Pilot-plant campaigns in glass-lined reactors of 2,000–4,000 L capacity have demonstrated that isolating the ethyl ester after coupling, rather than the free acid, improves the rejection of the des-cyano and regioisomeric impurities by a factor of 2–3 during a single reslurry in isopropanol at 0–5 °C. The ester is subsequently hydrolyzed with 2.0–2.5 eq of aqueous NaOH in ethanol at reflux, and the free acid is precipitated by pH adjustment to 2.5–3.0 with dilute HCl. Published data for the kinetic profile of this hydrolysis on production-scale equipment indicates a required hold time of 3–4 hours to achieve ≥ 99.9% conversion; incomplete hydrolysis left residual ester above 0.15% in the final API in eight of twelve initial qualification batches prior to implementing inline Raman monitoring.



Specification Parameters for GMP Intermediate Delivery


Parameter
Acceptance Criterion
Test Method
Appearance
White to off-white crystalline powder
Visual / Ph. Eur. 2.2.1
Assay (HPLC, anhydrous basis)
99.0–101.0%
In-house HPLC-UV 315 nm
Single largest unknown impurity
≤ 0.10%
HPLC-UV (area%)
Total impurities
≤ 0.30%
HPLC-UV (area%)
Residual palladium
≤ 10 ppm
ICP-MS (Ph. Eur. 2.2.58)
Water (Karl Fischer)
≤ 0.10%
Ph. Eur. 2.5.32
Residual ethanol
≤ 500 ppm
HS-GC (ICH Q3C)
Residual toluene
≤ 300 ppm
HS-GC (ICH Q3C)
Melting range
148–150 °C
DSC / capillary



If the material is stored above 30 °C in an environment exceeding 60% relative humidity, the crystalline lattice undergoes partial hydrolysis at the ester group within 14 days, generating free febuxostat acid and ethanol; this degradation is detectable as a secondary endotherm at 192–195 °C in DSC and as a splitting of the carbonyl stretch in FTIR (shift from 1712 cm⁻¹ to a doublet at 1712/1685 cm⁻¹). Warehousing in Europe and Southeast Asia has consequently adopted double polyethylene liners inside aluminum-laminated fiber drums, with desiccant pouches meeting MIL-D-3464E Type II specifications, and a controlled storage temperature of 2–8 °C. Once a container is opened in a manufacturing suite, the material must be discharged and processed within 8 hours or placed under nitrogen overlay until use, because static charge accumulation on the powder—measured with a Faraday pail electrometer as exceeding 0.5 µC/kg on several occasions—promotes rapid moisture uptake and agglomeration that interferes with the subsequent particle-size-dependent dissolution into the hydrolysis solvent.


Comparison with the methyl ester and the free acid in downstream processing

Property
Ethyl Ester (C₁₈H₂₀N₂O₃S)
Methyl Ester (C₁₇H₁₈N₂O₃S)
Free Acid (C₁₆H₁₆N₂O₃S)
Melting point
148–150 °C
162–164 °C
201–203 °C
Solubility in ethanol at 25 °C
8–10 mg/mL
4–5 mg/mL
1.5 mg/mL
Hydrolysis half-life (0.5 M NaOH, EtOH/H2O, reflux)
45–50 min
25–30 min
—
Typical coupling yield (Suzuki, identical conditions)
88–92%
85–89%
62–68%
Purification ease (single reslurry)
Removes > 95% of regioisomer
Removes ~ 80% of regioisomer
Co-precipitates regioisomer
Residual solvent after drying (ethyl ester route)
500 ppm ethanol + 300 ppm toluene
Methanol 3,000 ppm (ICH Class 2) limitation
No ester solvent, but acetic acid traces


The methyl ester, although hydrolyzed more rapidly, introduces methanol as a Class 2 solvent with a permitted daily exposure of 30 mg/day versus ethanol’s Class 3 (50 mg/day PDE), meaning that any residual methyl ester in the final febuxostat would require a dedicated limit and more frequent monitoring. The free acid, while eliminating the hydrolysis step entirely, exhibits markedly lower solubility in the toluene/ethanol coupling medium, causing palladium entrapment in the precipitated solid and pushing residual Pd above the 10 ppm ceiling without additional dithiocarbamate scrubbing, which adds a full shift to the manufacturing cycle in kilo-lab and pilot-plant settings. Therefore, the ethyl ester is designated as the regulatory starting material in multiple Type II DMFs filed with the US FDA, with the reductive coupling and ester hydrolysis comprising the final two chemical transformations before crystallization of the API.


HPLC method for assay and related substances

The compendial in-house method employs a C18 column (150 × 4.6 mm, 5 µm) thermostatted at 30 °C, with mobile phase A being 0.1% trifluoroacetic acid in water and mobile phase B acetonitrile, delivered in a linear gradient from 30% B to 80% B over 25 minutes at 1.0 mL/min. Under these conditions, the ethyl ester elutes at a relative retention time (RRT) of 1.00 (~14.2 min), while the critical process impurities—the des-cyano analog (RRT 0.89), the 2-methylpropyl positional isomer (RRT 1.12), and the amide hydrolysis byproduct (RRT 0.72)—are resolved with baseline separation (USP resolution ≥ 2.0). Detection wavelength is set at 315 nm, corresponding to the absorption maximum of the cyanobiphenyl chromophore. The method is linear over the range 0.05–150% of the nominal test concentration (1.0 mg/mL), with a limit of quantitation of 0.02% for known impurities. Forced degradation studies confirmed that exposing the powder to 105 °C for 48 hours produces an additional peak at RRT 1.32 identified by LC-MS as the decarboxylated ethyl ester, a degradant that must be controlled to ≤ 0.05% in material shipped for pivotal bio-batches.



Vessel preparation and nitrogen inerting prior to dissolution of the ester in dimethylformamide for the downstream coupling reaction is critical: trace oxygen reacts with the palladium(0) catalyst to form catalytically inactive palladium(II) oxide clusters, lowering turnover number below the design threshold of 500. Production operators at multiple CMO sites have observed that a single vacuum-nitrogen purge cycle to 50 mbar residual pressure, rather than the specified three cycles to 20 mbar, caused the catalyst loading to be increased from 0.5 mol% to 1.2 mol% to maintain conversion above 95% within 6 hours, increasing the residual Pd burden in the isolated ester by a factor of 4–5. The combination of the ethyl ester with amine bases stronger than triethylamine—for instance, N,N-diisopropylethylamine—at temperatures above 50 °C initiates transesterification with trace diethylamine present as a manufacturing byproduct in the amine source, generating the diethylamide impurity at levels up to 0.8% in the subsequent isolated product, which cannot be purged in the final recrystallization of febuxostat.